-
Notifications
You must be signed in to change notification settings - Fork 3
Description
What happened?
Issue in tsiex01 apparently.. to discuss , but just jotting it down
result
Duration of Treatment; Safety Analysis Set (Study jjcs - core)
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
Active Study Agent Difference in Means (95% CI)
Xanomeline High Dose Xanomeline Low Dose Combined Placebo Xanomeline High Dose vs Placebo Xanomeline Low Dose vs Placebo
Parameter N=53 N=73 N=126 N=59
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
Duration of treatment~[super a], ([unit])
Mean (SD) 17.41 (11.408) 20.46 (10.198) 19.18 (10.786) 18.64 (10.656) -1.23 (-5.23, 2.77) 1.82 (-1.88, 5.52)
Median 16.10 21.20 18.90 18.60
Min, max 0.2, 35.4 0.1, 37.9 0.1, 37.9 0.9, 37.2
Interquartile range 8.30, 27.80 14.70, 28.10 11.30, 28.00 9.30, 26.30
Total treatment (subject years) 922.9 (76.9) 1493.8 (124.5) 2416.7 (201.4) 1099.9 (91.7)
Duration of treatment, n (%)
0 to <3 months 7 (13.2%) 4 (5.5%) 11 (8.7%) 2 (3.4%)
3 to <6 months 5 (9.4%) 5 (6.8%) 10 (7.9%) 5 (8.5%)
6 to <9 months 3 (5.7%) 3 (4.1%) 6 (4.8%) 7 (11.9%)
9 to <12 months 4 (7.5%) 2 (2.7%) 6 (4.8%) 7 (11.9%)
12 to <15 months 6 (11.3%) 8 (11.0%) 14 (11.1%) 5 (8.5%)
15 to <18 months 3 (5.7%) 10 (13.7%) 13 (10.3%) 3 (5.1%)
18 to <21 months 5 (9.4%) 4 (5.5%) 9 (7.1%) 5 (8.5%)
21 to <24 months 1 (1.9%) 7 (9.6%) 8 (6.3%) 5 (8.5%)
24 to <27 months 3 (5.7%) 6 (8.2%) 9 (7.1%) 6 (10.2%)
27 to <30 months 6 (11.3%) 9 (12.3%) 15 (11.9%) 2 (3.4%)
30 to <33 months 5 (9.4%) 4 (5.5%) 9 (7.1%) 3 (5.1%)
33 to <36 months 5 (9.4%) 9 (12.3%) 14 (11.1%) 5 (8.5%)
36 to <39 months 0 2 (2.7%) 2 (1.6%) 4 (6.8%)
Duration of treatment~[super b], n (%)
<1 month 4 (7.5%) 1 (1.4%) 5 (4.0%) 1 (1.7%)
>=1 month 49 (92.5%) 72 (98.6%) 121 (96.0%) 58 (98.3%)
>=2 months 46 (86.8%) 71 (97.3%) 117 (92.9%) 58 (98.3%)
>=3 months 46 (86.8%) 69 (94.5%) 115 (91.3%) 57 (96.6%)
>=6 months 41 (77.4%) 64 (87.7%) 105 (83.3%) 52 (88.1%)
>=12 months 34 (64.2%) 59 (80.8%) 93 (73.8%) 38 (64.4%)
>=24 months 19 (35.8%) 30 (41.1%) 49 (38.9%) 20 (33.9%)
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
~{super a} Duration of treatment is defined as [(date of last dose of study treatment – date of first dose of study treatment) +1].
~{super b} Subjects are summarized in all applicable duration categories.
output_dir = tempdir()
export_as_docx_j(result,
-
tblid = "superscripttable", -
output_dir = out_dir, -
orientation = "landscape", -
markup_df = docx_markup_df)
Error in parse(text = str_after) :
:1:48: unexpected string constant
1: flextable::as_paragraph('Duration of treatment'', ([unit])'
^
Called from: parse(text = str_after)